The revenue stands at ₹1,625.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.37 per cent from ₹1,421.64 crore. This corresponds to a year-on-year *(YoY) growth of 24.82 per cent.
Operating Profit stands at ₹423.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.04 per cent from ₹333.41 crore. This corresponds to a year-on-year *(YoY) growth of 20.56 per cent.
PBDT stands at ₹491.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.18 per cent from ₹392.48 crore. This corresponds to a year-on-year *(YoY) growth of 31.92 per cent.
Profit Before Tax stands at ₹446.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.72 per cent from ₹347.11 crore. This corresponds to a year-on-year *(YoY) growth of 34.93 per cent.
Net Profit stands at ₹334.22 crore, reflecting a quarter-on-quarter *(QoQ) increase of 25.32 per cent from ₹266.70 crore. This represents a 30.89 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Ajanta Pharma | -1.83% | -2.79% | -4.70% | -3.23% | 15.69% | 38.70% |
| Anthem Bioscienc | -1.44% | -0.30% | -7.65% | 15.82% | 19.36% | 12.21% |
| Ipca Labs. | 1.29% | -0.45% | -0.72% | 2.28% | 30.50% | 47.53% |
| Glaxosmi. Pharma | 0.28% | -0.14% | -10.06% | 1.82% | 5.18% | -7.51% |
| Emcure Pharma | 0.48% | 0.96% | -6.28% | 4.29% | 13.60% | 37.35% |
| Wockhardt | 1.05% | -2.27% | -3.79% | 4.92% | 46.78% | 46.37% |
| Sai Life | -0.52% | -2.90% | -5.09% | 15.79% | 48.88% | 70.59% |
Chairman & Non Executive Dir. : Mannalal B Agrawal
Vice Chairman & Executive Dire : Madhusudan B Agrawal
ED / MD / Promoter : Yogesh Agrawal
ED / WTD / Joint MD / Promoter : Rajesh M Agrawal
Independent Non Exe. Director : David Rasquinha
Independent Non Exe. Director : Rajesh Shashikant Dalal
Independent Non Exe. Director : Medha Joshi
Independent Non Exe. Director : Simi Thapar
Senior Vice President & CS : Gaurang Shah